Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Effect of smoking history on [3H]nicotine binding in human postmortem brain.

Breese CR, Marks MJ, Logel J, Adams CE, Sullivan B, Collins AC, Leonard S.

J Pharmacol Exp Ther. 1997 Jul;282(1):7-13.

2.

Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists.

Collins AC, Bhat RV, Pauly JR, Marks MJ.

Ciba Found Symp. 1990;152:68-82; discussion 82-6. Review.

PMID:
2209260
3.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
4.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
5.

Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice.

Collins AC, Marks MJ, Pauly JR.

J Subst Abuse. 1989;1(3):273-86. Review.

PMID:
7580219
6.

The properties of brain nicotine receptors.

Morley BJ.

Pharmacol Ther. 1981;15(1):111-22. Review. No abstract available.

PMID:
7038713
7.

Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence.

Benowitz NL.

NIDA Res Monogr. 1990;99:12-29. Review. No abstract available.

PMID:
2267009
8.

Brain nicotine binding sites.

Wonnacott S.

Hum Toxicol. 1987 Sep;6(5):343-53. Review. No abstract available.

PMID:
3315965
9.

Smoking, nicotine and electrocortical activity.

Edwards JA, Warburton DM.

Pharmacol Ther. 1982;19(2):147-64. Review. No abstract available.

PMID:
6763706
Items per page

Supplemental Content

Support Center